Author:
Martínez-Rebollar Maria,Muñoz Ana,Pérez Iñaki,Hidalgo Susana,Brunet Mercè,Laguno Montserrat,González Ana,Calvo Marta,Loncà Montserrat,Blanco Jose Luis,Martínez Esteban,Gatell Jose Maria,Mallolas Josep
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference24 articles.
1. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria.;Moyle;Antivir Ther,2005
2. D:A:D Study Group, Sabin CA, Worm SW, et al.. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.;Lancet,2008
3. . Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.;Gallant;Clin Infect Dis,2005
4. . TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates.;De Meyer;Antimicrob Agents Chemother,2005
5. . Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.;Clotet;Lancet,2007
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献